# Cbre Group, Inc.: financial statements, quarterly

CBRE · NYSE · CIK 1138118 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbre.md) · [Financials](/companies/cbre/financials.md) · [Filings](/companies/cbre/filings.md) · [Insiders](/companies/cbre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.9 d](/filings/0001138118-26-000005.md) | [7.8](/filings/0001138118-25-000010.md) | [8.3](/filings/0001138118-25-000019.md) | [8.9](/filings/0001138118-25-000025.md) | [10.2 d](/filings/0001138118-26-000005.md) | [8.8](/filings/0001138118-26-000015.md) | [9.6](/filings/0001138118-26-000024.md) | [10.1](/filings/0001138118-26-000031.md) | [11.4 d](/filings/0001138118-26-000005.md) | [10.4](/filings/0001138118-26-000015.md) | [11.1](/filings/0001138118-26-000024.md) | [11.4](/filings/0001138118-26-000031.md) |
| Cost of revenue | $bn | [7.1 d](/filings/0001138118-26-000005.md) | [6.5](/filings/0001138118-25-000010.md) | [6.8](/filings/0001138118-25-000019.md) | [7.3](/filings/0001138118-25-000025.md) | [8.3 d](/filings/0001138118-26-000005.md) | [7.3](/filings/0001138118-26-000015.md) | [7.9](/filings/0001138118-26-000024.md) | [8.3](/filings/0001138118-26-000031.md) | [9.5 d](/filings/0001138118-26-000005.md) | [8.7](/filings/0001138118-26-000015.md) | [9.1](/filings/0001138118-26-000024.md) | [9.4](/filings/0001138118-26-000031.md) |
| Operating income | $bn | [0.5 d](/filings/0001138118-26-000005.md) | [0.2](/filings/0001138118-25-000010.md) | [0.2](/filings/0001138118-25-000019.md) | [0.4](/filings/0001138118-25-000025.md) | [0.6 d](/filings/0001138118-26-000005.md) | [0.3](/filings/0001138118-26-000015.md) | [0.4](/filings/0001138118-26-000024.md) | [0.5](/filings/0001138118-26-000031.md) | [0.6 d](/filings/0001138118-26-000005.md) | [0.5](/filings/0001138118-26-000015.md) | [0.4](/filings/0001138118-26-000024.md) | [0.6](/filings/0001138118-26-000031.md) |
| Interest expense | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.1 d](/filings/0001138118-26-000005.md) | [(0.0)](/filings/0001138118-25-000010.md) | [0.0](/filings/0001138118-25-000019.md) | [0.1](/filings/0001138118-25-000025.md) | [0.1 d](/filings/0001138118-26-000005.md) | [0.1](/filings/0001138118-26-000015.md) | [0.1](/filings/0001138118-26-000024.md) | [0.1](/filings/0001138118-26-000031.md) | [0.1 d](/filings/0001138118-26-000005.md) | [0.1](/filings/0001138118-26-000015.md) | [0.1](/filings/0001138118-26-000024.md) | [0.1](/filings/0001138118-26-000031.md) |
| Net income | $bn | [0.5 d](/filings/0001138118-26-000005.md) | [0.1](/filings/0001138118-25-000010.md) | [0.1](/filings/0001138118-25-000019.md) | [0.2](/filings/0001138118-25-000025.md) | [0.5 d](/filings/0001138118-26-000005.md) | [0.2](/filings/0001138118-26-000015.md) | [0.2](/filings/0001138118-26-000024.md) | [0.4](/filings/0001138118-26-000031.md) | [0.4 d](/filings/0001138118-26-000005.md) | [0.3](/filings/0001138118-26-000015.md) | [0.2](/filings/0001138118-26-000024.md) | [0.4](/filings/0001138118-26-000031.md) |
| Diluted EPS | $ per share | not reported | [0.41](/filings/0001138118-25-000010.md) | [0.42](/filings/0001138118-25-000019.md) | [0.73](/filings/0001138118-25-000025.md) | not reported | [0.54](/filings/0001138118-26-000015.md) | [0.72](/filings/0001138118-26-000024.md) | [1.21](/filings/0001138118-26-000031.md) | not reported | [1.07](/filings/0001138118-26-000015.md) | [0.69](/filings/0001138118-26-000024.md) | [1.52](/filings/0001138118-26-000031.md) |
| Basic EPS | $ per share | not reported | [0.41](/filings/0001138118-25-000010.md) | [0.42](/filings/0001138118-25-000019.md) | [0.73](/filings/0001138118-25-000025.md) | not reported | [0.54](/filings/0001138118-26-000015.md) | [0.72](/filings/0001138118-26-000024.md) | [1.22](/filings/0001138118-26-000031.md) | not reported | [1.08](/filings/0001138118-26-000015.md) | [0.70](/filings/0001138118-26-000024.md) | [1.53](/filings/0001138118-26-000031.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.3](/filings/0001138118-25-000005.md) | [1.0](/filings/0001138118-24-000014.md) | [0.9](/filings/0001138118-24-000023.md) | [1.0](/filings/0001138118-24-000029.md) | [1.1](/filings/0001138118-26-000005.md) | [1.4](/filings/0001138118-25-000010.md) | [1.4](/filings/0001138118-25-000019.md) | [1.7](/filings/0001138118-25-000025.md) | [1.9](/filings/0001138118-26-000031.md) | [1.7](/filings/0001138118-26-000015.md) | [1.5](/filings/0001138118-26-000024.md) | [1.7](/filings/0001138118-26-000031.md) |
| Current assets | $bn | [9.7](/filings/0001138118-25-000005.md) | [9.4](/filings/0001138118-24-000014.md) | [9.7](/filings/0001138118-24-000023.md) | [10.6](/filings/0001138118-24-000029.md) | [10.0](/filings/0001138118-26-000005.md) | [10.8](/filings/0001138118-25-000010.md) | [12.0](/filings/0001138118-25-000019.md) | [12.6](/filings/0001138118-25-000025.md) | [13.5](/filings/0001138118-26-000031.md) | [12.7](/filings/0001138118-26-000015.md) | [12.9](/filings/0001138118-26-000024.md) | [13.7](/filings/0001138118-26-000031.md) |
| Total assets | $bn | [22.5](/filings/0001138118-25-000005.md) | [23.0](/filings/0001138118-24-000014.md) | [23.5](/filings/0001138118-24-000023.md) | [24.8](/filings/0001138118-24-000029.md) | [24.4](/filings/0001138118-26-000005.md) | [26.4](/filings/0001138118-25-000010.md) | [27.7](/filings/0001138118-25-000019.md) | [28.6](/filings/0001138118-25-000025.md) | [30.9](/filings/0001138118-26-000031.md) | [30.2](/filings/0001138118-26-000015.md) | [30.5](/filings/0001138118-26-000024.md) | [31.3](/filings/0001138118-26-000031.md) |
| Current liabilities | $bn | [8.2](/filings/0001138118-25-000005.md) | [8.2](/filings/0001138118-24-000014.md) | [8.6](/filings/0001138118-24-000023.md) | [9.4](/filings/0001138118-24-000029.md) | [9.3](/filings/0001138118-26-000005.md) | [10.9](/filings/0001138118-25-000010.md) | [10.6](/filings/0001138118-25-000019.md) | [11.2](/filings/0001138118-25-000025.md) | [12.3](/filings/0001138118-26-000031.md) | [11.8](/filings/0001138118-26-000015.md) | [11.3](/filings/0001138118-26-000024.md) | [11.7](/filings/0001138118-26-000031.md) |
| Total liabilities | $bn | [13.5](/filings/0001138118-25-000005.md) | [13.9](/filings/0001138118-24-000014.md) | [14.3](/filings/0001138118-24-000023.md) | [15.3](/filings/0001138118-24-000029.md) | [15.2](/filings/0001138118-26-000005.md) | [17.4](/filings/0001138118-25-000010.md) | [18.7](/filings/0001138118-25-000019.md) | [19.3](/filings/0001138118-25-000025.md) | [21.3](/filings/0001138118-26-000031.md) | [20.9](/filings/0001138118-26-000015.md) | [21.3](/filings/0001138118-26-000024.md) | [21.9](/filings/0001138118-26-000031.md) |
| Long-term debt | $bn | [2.8](/filings/0001138118-25-000005.md) | [3.3](/filings/0001138118-24-000014.md) | [3.3](/filings/0001138118-24-000023.md) | [3.3](/filings/0001138118-24-000029.md) | [3.2](/filings/0001138118-26-000005.md) | [3.2](/filings/0001138118-25-000010.md) | [4.3](/filings/0001138118-25-000019.md) | [4.3](/filings/0001138118-25-000025.md) | [5.1](/filings/0001138118-26-000031.md) | [5.0](/filings/0001138118-26-000015.md) | [5.7](/filings/0001138118-26-000024.md) | [5.7](/filings/0001138118-26-000031.md) |
| Current portion of debt | $bn | [0.0](/filings/0001138118-25-000005.md) | [0.0](/filings/0001138118-24-000014.md) | [0.0](/filings/0001138118-24-000023.md) | [0.0](/filings/0001138118-24-000029.md) | [0.0](/filings/0001138118-26-000005.md) | [0.7](/filings/0001138118-25-000010.md) | [0.1](/filings/0001138118-25-000019.md) | [0.1](/filings/0001138118-25-000025.md) | [0.1](/filings/0001138118-26-000031.md) | [0.1](/filings/0001138118-26-000015.md) | [0.1](/filings/0001138118-26-000024.md) | [0.1](/filings/0001138118-26-000031.md) |
| Short-term borrowings | $bn | [0.7](/filings/0001138118-25-000005.md) | not reported | not reported | not reported | [0.9](/filings/0001138118-26-000005.md) | [2.8](/filings/0001138118-25-000010.md) | [2.8](/filings/0001138118-25-000019.md) | [2.7](/filings/0001138118-25-000025.md) | [2.5](/filings/0001138118-26-000031.md) | [2.9](/filings/0001138118-26-000015.md) | [2.3](/filings/0001138118-26-000024.md) | [2.1](/filings/0001138118-26-000031.md) |
| Shareholders' equity | $bn | [8.3](/filings/0001138118-25-000005.md) | [8.3](/filings/0001138118-24-000014.md) | [8.4](/filings/0001138118-24-000023.md) | [8.7](/filings/0001138118-24-000029.md) | [8.4](/filings/0001138118-26-000005.md) | [8.3](/filings/0001138118-25-000010.md) | [8.3](/filings/0001138118-25-000019.md) | [8.5](/filings/0001138118-25-000025.md) | [8.9](/filings/0001138118-26-000031.md) | [8.5](/filings/0001138118-26-000015.md) | [8.4](/filings/0001138118-26-000024.md) | [8.7](/filings/0001138118-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [853 d](/filings/0001138118-26-000005.md) | [(492)](/filings/0001138118-25-000010.md) | [287 d](/filings/0001138118-25-000019.md) | [573 d](/filings/0001138118-25-000025.md) | [1,340 d](/filings/0001138118-26-000005.md) | [(546)](/filings/0001138118-26-000015.md) | [57.0 d](/filings/0001138118-26-000024.md) | [827 d](/filings/0001138118-26-000031.md) | [1,221 d](/filings/0001138118-26-000005.md) | [(825)](/filings/0001138118-26-000015.md) | [138 d](/filings/0001138118-26-000024.md) | [869 d](/filings/0001138118-26-000031.md) |
| Capital expenditure | $m | [94.0 d](/filings/0001138118-26-000005.md) | [68.0](/filings/0001138118-25-000010.md) | [67.0 d](/filings/0001138118-25-000019.md) | [79.0 d](/filings/0001138118-25-000025.md) | [93.0 d](/filings/0001138118-26-000005.md) | [64.0](/filings/0001138118-26-000015.md) | [74.0 d](/filings/0001138118-26-000024.md) | [84.0 d](/filings/0001138118-26-000031.md) | [144 d](/filings/0001138118-26-000005.md) | [81.0](/filings/0001138118-26-000015.md) | [114 d](/filings/0001138118-26-000024.md) | [126 d](/filings/0001138118-26-000031.md) |
| Share repurchases | $m | [19.0 d](/filings/0001138118-26-000005.md) | [0.0](/filings/0001138118-25-000010.md) | [47.0 d](/filings/0001138118-25-000019.md) | [63.0 d](/filings/0001138118-25-000025.md) | [517 d](/filings/0001138118-26-000005.md) | [418](/filings/0001138118-26-000015.md) | [262 d](/filings/0001138118-26-000024.md) | [0.0 d](/filings/0001138118-26-000031.md) | [288 d](/filings/0001138118-26-000005.md) | [530](/filings/0001138118-26-000015.md) | [410 d](/filings/0001138118-26-000024.md) | [218 d](/filings/0001138118-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [315](/filings/0001138118-24-000014.md) | [314](/filings/0001138118-24-000023.md) | [312](/filings/0001138118-24-000029.md) | [309](/filings/0001138118-25-000010.md) | [308](/filings/0001138118-25-000019.md) | [308](/filings/0001138118-25-000025.md) | [303](/filings/0001138118-26-000015.md) | [300](/filings/0001138118-26-000024.md) | [300](/filings/0001138118-26-000031.md) | [297](/filings/0001138118-26-000015.md) | [294](/filings/0001138118-26-000024.md) | [292](/filings/0001138118-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 288,196,254 at 2026-10-20, from the cover of the [10-Q filed 2026-10-22](/filings/0001138118-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.